| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.82B | 84.68B | 86.15B | 79.18B | 64.22B | 44.65B |
| Gross Profit | 54.68B | 56.77B | 59.28B | 54.20B | 43.85B | 28.76B |
| EBITDA | 22.41B | 22.30B | 28.55B | 26.07B | 22.49B | 12.54B |
| Net Income | 10.98B | 12.55B | 15.17B | 14.08B | 12.04B | 4.70B |
Balance Sheet | ||||||
| Total Assets | 141.57B | 149.19B | 143.69B | 134.65B | 125.31B | 108.67B |
| Cash, Cash Equivalents and Short-Term Investments | 12.33B | 13.59B | 11.26B | 10.85B | 10.56B | 20.71B |
| Total Debt | 39.64B | 41.20B | 38.88B | 35.15B | 34.84B | 37.48B |
| Total Liabilities | 74.70B | 79.90B | 80.99B | 78.04B | 76.40B | 69.84B |
| Stockholders Equity | 65.30B | 67.52B | 61.02B | 55.11B | 47.12B | 37.41B |
Cash Flow | ||||||
| Free Cash Flow | 14.37B | 13.37B | 10.60B | 12.75B | 15.39B | 8.43B |
| Operating Cash Flow | 19.53B | 18.93B | 18.40B | 17.84B | 18.65B | 10.90B |
| Investing Cash Flow | -5.97B | -6.54B | -8.31B | -5.92B | -15.98B | -2.94B |
| Financing Cash Flow | -12.40B | -10.72B | -9.40B | -12.69B | -15.16B | 7.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | €219.96B | 49.17 | 27.36% | 1.24% | 10.31% | 0.54% | |
78 Outperform | €314.01B | 28.70 | 16.88% | 2.07% | -3.24% | -21.24% | |
76 Outperform | €105.90B | 23.24 | 19.54% | 2.33% | -3.24% | -21.65% | |
69 Neutral | €2.11B | 15.05 | 20.31% | 3.60% | 9.68% | 19.46% | |
68 Neutral | €126.94B | 52.67 | 6.19% | 1.44% | 5.45% | 2.86% | |
62 Neutral | €37.09B | 50.88 | 4.91% | 2.03% | -14.56% | -64.91% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |